These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 26504821)
21. Bilateral tibial Brodie's abscess in a young patient treated with BAG-S53P4: case report. Cossio A; Graci J; Lombardo AS; Turati M; Melzi ML; Bigoni M; Zatti G Ital J Pediatr; 2019 Jul; 45(1):91. PubMed ID: 31349859 [TBL] [Abstract][Full Text] [Related]
22. 18F-NaF PET/CT imaging of bone formation induced by bioactive glass S53P4 after mastoid obliteration. Timmermans AJ; Quak JJ; Hagen PJ; Colnot DR Eur J Hybrid Imaging; 2019 Oct; 3(1):18. PubMed ID: 34191153 [TBL] [Abstract][Full Text] [Related]
23. Treatment of infected tibial non-unions using a BMAC and S53P4 BAG combination for reconstruction of segmental bone defects: A clinical case series. Van Vugt TAG; Geurts JAP; Blokhuis TJ Injury; 2021 Jun; 52 Suppl 2():S67-S71. PubMed ID: 33039177 [TBL] [Abstract][Full Text] [Related]
24. Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience. Steinhausen E; Lefering R; Glombitza M; Brinkmann N; Vogel C; Mester B; Dudda M J Bone Jt Infect; 2021; 6(4):73-83. PubMed ID: 34084694 [No Abstract] [Full Text] [Related]
25. Pilot Experience on the Use of S53P4 Bioactive Glass in the Surgical Management of Diabetic Foot Osteomyelitis. Iacopi E; Pieruzzi L; Goretti C; Piaggesi A Int J Low Extrem Wounds; 2022 Mar; 21(1):57-64. PubMed ID: 32506987 [TBL] [Abstract][Full Text] [Related]
26. Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study. Van Vugt TAG; Heidotting J; Arts JJ; Ploegmakers JJW; Jutte PC; Geurts JAP J Bone Jt Infect; 2021; 6(9):413-421. PubMed ID: 34804776 [No Abstract] [Full Text] [Related]
27. Cutaneous and Labyrinthine Tolerance of Bioactive Glass S53P4 in Mastoid and Epitympanic Obliteration Surgery: Prospective Clinical Study. Bernardeschi D; Nguyen Y; Russo FY; Mosnier I; Ferrary E; Sterkers O Biomed Res Int; 2015; 2015():242319. PubMed ID: 26504792 [TBL] [Abstract][Full Text] [Related]
28. A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors. Lindfors NC; Koski I; Heikkilä JT; Mattila K; Aho AJ J Biomed Mater Res B Appl Biomater; 2010 Jul; 94(1):157-64. PubMed ID: 20524190 [TBL] [Abstract][Full Text] [Related]
29. Posterolateral spondylodesis using bioactive glass S53P4 and autogenous bone in instrumented unstable lumbar spine burst fractures. A prospective 10-year follow-up study. Rantakokko J; Frantzén JP; Heinänen J; Kajander S; Kotilainen E; Gullichsen E; Lindfors NC Scand J Surg; 2012; 101(1):66-71. PubMed ID: 22414472 [TBL] [Abstract][Full Text] [Related]
30. S53P4 BIOACTIVE GLASS PUTTY IN THE LOCAL TREATMENT OF CAVITARY CHRONIC OSTEOMYELITIS. Reis GNBD; Cuba GT; Targa WHC; Miras PSC; Bongiovanni JC; Salles MJ; Reis FBD; Dell'aquila AM Acta Ortop Bras; 2023; 31(1):e258453. PubMed ID: 36844131 [TBL] [Abstract][Full Text] [Related]
31. Bioactive glass, a new tool for the treatment in the diabetic foot recalcitrant osteomyelitis: A case series with 24-month follow-up. Rodríguez Á; Parra G; Cuervas-Mons M Foot (Edinb); 2021 Sep; 48():101831. PubMed ID: 34390944 [TBL] [Abstract][Full Text] [Related]
32. Cost-Effectiveness Study of One-Stage Treatment of Chronic Osteomyelitis with Bioactive Glass S53P4. Geurts J; van Vugt T; Thijssen E; Arts JJ Materials (Basel); 2019 Sep; 12(19):. PubMed ID: 31574970 [TBL] [Abstract][Full Text] [Related]
33. Composition dependent mechanical behaviour of S53P4 bioactive glass putty for bone defect grafting. van Gestel NAP; Hulsen DJW; Geurts J; Hofmann S; Ito K; Arts JJ; van Rietbergen B J Mech Behav Biomed Mater; 2017 May; 69():301-306. PubMed ID: 28131065 [TBL] [Abstract][Full Text] [Related]
34. Effects of S53P4 bioactive glass on osteoblastic cell and biomaterial surface interaction. Pérez-Tanoira R; Kinnari TJ; Hyyrynen T; Soininen A; Pietola L; Tiainen VM; Konttinen YT; Aarnisalo AA J Mater Sci Mater Med; 2015 Oct; 26(10):246. PubMed ID: 26411442 [TBL] [Abstract][Full Text] [Related]
35. Treatment of Cavitary Bone Defects in Chronic Osteomyelitis: Biogactive glass S53P4 vs. Calcium Sulphate Antibiotic Beads. Ferrando A; Part J; Baeza J J Bone Jt Infect; 2017; 2(4):194-201. PubMed ID: 29119078 [TBL] [Abstract][Full Text] [Related]
36. Use of bone graft substitutes in the management of tibial plateau fractures. Goff T; Kanakaris NK; Giannoudis PV Injury; 2013 Jan; 44 Suppl 1():S86-94. PubMed ID: 23351879 [TBL] [Abstract][Full Text] [Related]
37. Repair of orbital floor fractures with bioactive glass implants. Aitasalo K; Kinnunen I; Palmgren J; Varpula M J Oral Maxillofac Surg; 2001 Dec; 59(12):1390-5; discussion 1395-6. PubMed ID: 11732018 [TBL] [Abstract][Full Text] [Related]
38. Molecular basis for action of bioactive glasses as bone graft substitute. Välimäki VV; Aro HT Scand J Surg; 2006; 95(2):95-102. PubMed ID: 16821652 [TBL] [Abstract][Full Text] [Related]
39. Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis. McAndrew J; Efrimescu C; Sheehan E; Niall D Ir J Med Sci; 2013 Sep; 182(3):509-11. PubMed ID: 23292733 [TBL] [Abstract][Full Text] [Related]
40. The use of bioactive glass S53P4 in the treatment of an infected Charcot foot: a case report. Godoy-Santos AL; Rosemberg LA; de Cesar-Netto C; Armstrong DG J Wound Care; 2019 Jan; 28(Sup1):S14-S17. PubMed ID: 30724119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]